[HTML][HTML] Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity

M Pandey, AK Singh, R Thakare, S Talwar… - Scientific Reports, 2017 - nature.com
Indiscriminate use of antibiotics globally has lead to an increase in emergence of drug-
resistant pathogens under both nosocomial, as well as more worryingly, in community …

Novel antibacterial compounds and their drug targets-successes and challenges

AA Kaczor, A Polski, K Sobótka-Polska… - Current medicinal …, 2017 - ingentaconnect.com
Infectious diseases are one of the most important and urgent health problems in the world.
According to the World Health Organization (WHO) statistics, infectious and parasitic …

Novel antibacterial agents: an emergent need to win the battle against infections

NG Simoes, AF Bettencourt, N Monge… - Mini Reviews in …, 2017 - ingentaconnect.com
Background: Multiple strategies have been recommended for prevention and control of
antibacterial resistance. Solutions will need to be found soon if we are not to run the serious …

Broad activity of diphenyleneiodonium analogues against Mycobacterium tuberculosis, malaria parasites and bacterial pathogens

N Nguyen, DW Wilson, G Nagalingam… - European Journal of …, 2018 - Elsevier
In this study, a structure-activity relationship (SAR) compound series based on the NDH-2
inhibitor diphenyleneiodonium (DPI) was synthesised. Compounds were evaluated primarily …

Re-engineering nalidixic acid's chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens

R Peraman, RV Varma, YP Reddy - Bioorganic & medicinal chemistry …, 2015 - Elsevier
Occurrence of antibacterial and antimycobacterial resistance stimulated a thrust to discover
new drugs for infectious diseases. Herein we report the work on re-engineering nalidixic …

Synthesis, ADME Study, and antimicrobial evaluation of novel naphthalene-based derivatives

SF Jasim, YF Mustafa - 2022 - sid.ir
In recent times, many researchers in pharmaceutical chemistry have been preoccupied with
the quest for new potent anti-infective agents to combat Antimicrobial resistance. A novel …

Recent advances in antibacterial agents

Q Kong, Y Yang - Bioorganic & Medicinal Chemistry Letters, 2021 - Elsevier
Antimicrobial resistance is a global challenge and the effectiveness of old antibiotics is
decreasing. Discovery and development of antibacterial agents have been accelerated to …

[HTML][HTML] Evaluation of novel compounds as anti-bacterial or anti-virulence agents

B Filipić, D Ušjak, MH Rambaher, S Oljacic… - Frontiers in Cellular …, 2024 - frontiersin.org
Antimicrobial resistance is a global threat, leading to an alarming increase in the prevalence
of bacterial infections that can no longer be treated with available antibiotics. The World …

An unanticipated discovery of novel naphthalimidopropanediols as potential broad-spectrum antibacterial members

PL Zhang, MH Laiche, YL Li, WW Gao, JM Lin… - European Journal of …, 2022 - Elsevier
Constructing a new antibacterial structural framework is an effective strategy to combat drug
resistance. This work discovered a class of naphthalimidopropanediols (NIOLs) as a novel …

Diphenylether-Modified 1,2-Diamines with Improved Drug Properties for Development against Mycobacterium tuberculosis

MH Foss, S Pou, PM Davidson, JL Dunaj… - ACS infectious …, 2016 - ACS Publications
New treatments for tuberculosis infection are critical to combat the emergence of multidrug-
and extensively drug-resistant Mycobacterium tuberculosis (Mtb). We report the …